Most healthcare stakeholders have been open and aggressive in adopting digital health. There has been, however, one significant holdout that has been extremely reluctant to dive in–the pharmaceutical industry.
But today is a new day and Pharma is waking up to digital health! They are beginning to engage with these strategic tools to improve everything from clinical trials, drug discovery, drug design, new business opportunities, better patient relations and much more.
Join us as we convene three veteran pharma experts for this important discussion on the here, the now, and the future of digital health’s role in the legacy-prone pharma industry.